Tema Neuroscience And Etf Profile

MNTL Etf   26.12  0.22  0.85%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Tema Neuroscience is selling for 26.12 as of the 28th of November 2024. This is a 0.85 percent increase since the beginning of the trading day. The etf's lowest day price was 26.12. Tema Neuroscience has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Tema Neuroscience and are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Tema Neuroscience is entity of United States. It is traded as Etf on NASDAQ exchange. More on Tema Neuroscience and

Moving together with Tema Etf

  0.71XLV Health Care SelectPairCorr
  0.76VHT Vanguard Health CarePairCorr
  0.9IBB iShares Biotechnology ETFPairCorr
  0.85XBI SPDR SP BiotechPairCorr
  0.7IXJ iShares Global HealthcarePairCorr

Moving against Tema Etf

  0.37VO Vanguard Mid CapPairCorr
  0.32VB Vanguard Small CapPairCorr

Tema Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationStrategy ETFs, Theme ETFs, Health (View all Sectors)
IssuerTema Global
Inception Date2024-01-22
Entity TypeRegulated Investment Company
Asset Under Management11.39 Million
Asset TypeEquity
CategoryStrategy
FocusTheme
Market ConcentrationBlended Development
RegionGlobal
AdministratorUS Bancorp Fund Services, LLC
AdvisorTema Global Limited
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Portfolio ManagerDavid Song, Yuri Khodjamirian
Transfer AgentUS Bancorp Fund Services, LLC
ExchangeNASDAQ
Number of Constituents49.0
Market MakerOld Mission
Total Expense0.99
Management Fee0.99
200 Day M A25.9416
Country NameUSA
50 Day M A26.4433
CodeMNTL
Updated At27th of November 2024
NameTema Neuroscience and Mental Health ETF
Currency NameUS Dollar
Currency CodeUSD
Open FigiBBG01L14NCJ0
TypeETF
Tema Neuroscience and [MNTL] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Strategy ETFs. Tema Neuroscience now have in assets.
Check Tema Neuroscience Probability Of Bankruptcy

Geographic Allocation (%)

Tema Neuroscience Currency Exposure

Tema Neuroscience and holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Tema Neuroscience will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Tema Neuroscience and.

Top Tema Neuroscience and Etf Constituents

DYNDyne TherapeuticsStockHealth Care
VRTXVertex PharmaceuticalsStockHealth Care
ARVNArvinasStockHealth Care
IMVTImmunovantStockHealth Care
MDTMedtronic PLCStockHealth Care
PENPenumbraStockHealth Care
CPRXCatalyst PharmaceuticalsStockHealth Care
SHLSiemens Healthineers AGStockMedical Devices
More Details

Tema Neuroscience Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tema Neuroscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Tema Neuroscience Against Markets

When determining whether Tema Neuroscience is a strong investment it is important to analyze Tema Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tema Neuroscience's future performance. For an informed investment choice regarding Tema Etf, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Tema Neuroscience and. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
The market value of Tema Neuroscience is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Tema Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Neuroscience's market value can be influenced by many factors that don't directly affect Tema Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.